Report for: Fluoxetine versus other types of pharmacotherapy for depression

Title	Fluoxetine versus other types of pharmacotherapy for depression
Published in	Cochrane database of systematic reviews, July 2013
DOI	10.1002/14651858.cd004185.pub3
Pubmed ID	24353997
Authors	Laura R Magni, Marianna Purgato, Chiara Gastaldon, Davide Papola, Toshi A Furukawa, Andrea Cipriani, Corrado Barbui
Abstract	Depression is common in primary care and is associated with marked personal, social and economic morbidity, thus creating significant demands on service providers. The antidepressant fluoxetine has been studied in many randomised controlled trials (RCTs) in comparison with other conventional and unconventional antidepressants. However, these studies have produced conflicting findings.Other systematic reviews have considered selective serotonin reuptake inhibitor (SSRIs) as a group which limits the applicability of the indings for fluoxetine alone. Therefore, this review intends to provide specific and clinically useful information regarding the effects of fluoxetine for depression compared with tricyclics (TCAs), SSRIs, serotonin-noradrenaline reuptake inhibitors (SNRIs), monoamineoxidase inhibitors (MAOIs) and newer agents, and other conventional and unconventional agents.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United States	2	20%
France	1	10%
Spain	1	10%
Unknown	6	60%

Demographic breakdown

Type	Count	As %
Members of the public	8	80%
Science communicators (journalists, bloggers, editors)	1	10%
Scientists	1	10%

Mendeley readers

The data shown below were compiled from readership statistics for 422 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United Kingdom	3	<1%
Germany	3	<1%
Colombia	1	<1%
Canada	1	<1%
Egypt	1	<1%
Unknown	413	98%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	67	16%
Student > Bachelor	65	15%
Researcher	40	9%
Student > Ph. D. Student	39	9%
Student > Postgraduate	33	8%
Other	75	18%
Unknown	103	24%

Readers by discipline	Count	As %
Medicine and Dentistry	118	28%
Psychology	46	11%
Nursing and Health Professions	34	8%
Agricultural and Biological Sciences	23	5%
Pharmacology, Toxicology and Pharmaceutical Science	22	5%
Other	65	15%
Unknown	114	27%

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2021.

All research outputs

#1,074,017

of 23,549,388 outputs

Outputs from Cochrane database of systematic reviews

#2,387

of 12,733 outputs

Outputs of similar age

#8,493

of 173,469 outputs

Outputs of similar age from Cochrane database of systematic reviews

#52

of 306 outputs

Altmetric has tracked 23,549,388 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,733 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.0. This one has done well, scoring higher than 81% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,469 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.

We're also able to compare this research output to 306 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.

Cochrane Database of Systematic Reviews

Fluoxetine versus other types of pharmacotherapy for depression

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context